A host of evaluation methodologies are defining ‘value’ in drug prices
By Jason Shafrin, PhD, Precision Health Economics
Advertisement
Articles by By Jason Shafrin, PhD, Precision Health Economics
Advertisement
Latest Updated Articles
- Value frameworks are here: What to do about them?
September 1st 2016
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Health Care Doesn't Have a Data Problem. It Has an Activation Problem.
2
Where Connected Pharmacovigilance Is Headed Next
3
Q&A: Why Managed Care Still Doubts TrumpRx's Savings Claims
4
Why the Digital Waiting Room Is Health Care's Most Valuable Untapped Asset
5